Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

Recent Study: ImmunoGen, Inc. - Product Pipeline Review - 2014


Print article Print article
2014-03-04 13:46:34 - New Pharmaceuticals market report from Global Markets Direct: "ImmunoGen, Inc. - Product Pipeline Review - 2014"

Global Market Direct's pharmaceuticals report, "ImmunoGen, Inc. - Product Pipeline Review - 2014" provides data on the ImmunoGen, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, ImmunoGen, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from ImmunoGen, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

Full Report Details at
- www.fastmr.com/prod/778149_immunogen_inc_product_pipeline_review ..

Report Scope

* ImmunoGen, Inc. - Brief ImmunoGen, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
*

Review of current pipeline of ImmunoGen, Inc. human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of ImmunoGen, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the ImmunoGen, Inc.'s pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Reasons to Get this Report

* Evaluate ImmunoGen, Inc.'s strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of ImmunoGen, Inc. in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the ImmunoGen, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with ImmunoGen, Inc..
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of ImmunoGen, Inc. and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
List of Tables
List of Figures
ImmunoGen, Inc. Snapshot
ImmunoGen, Inc. Overview
Key Information
Key Facts
ImmunoGen, Inc. - Research and Development Overview
Key Therapeutic Areas
ImmunoGen, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
ImmunoGen, Inc. - Pipeline Products Glance
ImmunoGen, Inc. - Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
ImmunoGen, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
ImmunoGen, Inc. - Drug Profiles
IMGN-289
Product Description
Mechanism of Action
R&D Progress
IMGN-529
Product Description
Mechanism of Action
R&D Progress
IMGN-853
Product Description
Mechanism of Action
R&D Progress
lorvotuzumab mertansine
Product Description
Mechanism of Action
R&D Progress
PC-61
Product Description
Mechanism of Action
R&D Progress
huHER3-8
Product Description
Mechanism of Action
R&D Progress
ImmunoGen, Inc. - Pipeline Analysis
ImmunoGen, Inc. - Pipeline Products by Therapeutic Class
ImmunoGen, Inc. - Pipeline Products by Target
ImmunoGen, Inc. - Pipeline Products by Route of Administration
ImmunoGen, Inc. - Pipeline Products by Molecule Type
ImmunoGen, Inc. - Pipeline Products by Mechanism of Action
ImmunoGen, Inc. - Recent Pipeline Updates
ImmunoGen, Inc. - Dormant Projects
ImmunoGen, Inc. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
AVE-1642
AVE-9633
cantuzumab ravtansine
IMGN-388
lorvotuzumab mertansine
Oncolysin B
ImmunoGen, Inc. - Company Statement
ImmunoGen, Inc. - Locations And Subsidiaries
Head Office
ImmunoGen, Inc. - Key Manufacturing Facilities
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
ImmunoGen, Inc., Key Information
ImmunoGen, Inc., Key Facts
ImmunoGen, Inc. - Pipeline by Indication, 2014
ImmunoGen, Inc. - Pipeline by Stage of Development, 2014
ImmunoGen, Inc. - Monotherapy Products in Pipeline, 2014
ImmunoGen, Inc. - Partnered Products in Pipeline, 2014
ImmunoGen, Inc. - Partnered Products/ Combination Treatment Modalities, 2014
ImmunoGen, Inc. - Out-Licensed Products in Pipeline, 2014
ImmunoGen, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2014
ImmunoGen, Inc. - Phase I, 2014
ImmunoGen, Inc. - Preclinical, 2014
ImmunoGen, Inc. - Discovery, 2014
ImmunoGen, Inc. - Pipeline by Therapeutic Class, 2014
ImmunoGen, Inc. - Pipeline by Target, 2014
ImmunoGen, Inc. - Pipeline by Route of Administration, 2014
ImmunoGen, Inc. - Pipeline by Molecule Type, 2014
ImmunoGen, Inc. - Pipeline Products by Mechanism of Action, 2014
ImmunoGen, Inc. - Recent Pipeline Updates, 2014
ImmunoGen, Inc. - Dormant Developmental Projects,2014

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=778149&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com